Our research goal is the translation of laboratory findings into treatments for eye diseases and the prevention of blindness.
By 2006, almost $6 million in funding provided for 25 clinical trials (9 federal; 16 industry) and 15 federal research grants. A number of “firsts” have occurred at the Eye Center, many during the past 20 years: pivotal clinical trials, innovative treatments and procedures for numerous vision disorders, and the growth of a brilliant research team.
J.H. Boatright, PhD
Robert L. Church, PhD
Vincent Thomas Ciavatta, PhD
Henry F. Edelhauser, PhD
Rashidul Haque, PhD
P. Michael Iuvone, PhD
Bernard E. McCarey, PhD
John M. Nickerson, PhD
Machelle T. Pardue, PhD
Paul W. Wong, PhD
Hua Yang, MD, PhD
Edelhauser Co-editor of New Textbook on Drug Delivery to the Back of the Eye
Sept. 30, 2011 | (ATLANTA) A new textbook, Drug Product Development for the Back of the Eye (aapspress/Springer), edited by Emory Eye Center researcher Henry F. Edelhauser, PhD and Uday B. Kompella, PhD, of the University of Colorado, explores approaches for a delivery system to get drugs to the back of the eye.
Research Director Michael
Iuvone Appointed to Endowed
Research Chair
(ATLANTA) P. Michael Iuvone, PhD, who recently joined Emory Eye Center
as director of research, has been appointed to the Sylvia Montag
Ferst and Frank W. Ferst Endowed Research Chair.
Molecular Vision is a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system (ocular and cortical).
1365-B Clifton Road NE, Atlanta GA 30322 | Copyright © Emory Eye Center 2012. All Rights Reserved.